Medtronic plc (MDT)

IE — Healthcare Sector
Peers:   EW  ABT  BSX  ZBH  SYK  DXCM  PODD  TNDM  ALGN 

Automate Your Wheel Strategy on MDT

With Tiblio's Option Bot, you can configure your own wheel strategy including MDT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol MDT
  • Rev/Share 25.8882
  • Book/Share 38.6892
  • PB 2.1547
  • Debt/Equity 0.5387
  • CurrentRatio 1.9014
  • ROIC 0.0615

 

  • MktCap 106425169200.0
  • FreeCF/Share 4.2631
  • PFCF 19.4668
  • PE 24.9797
  • Debt/Assets 0.2957
  • DivYield 0.0337
  • ROE 0.0869

 

  • Rating B
  • Score 3
  • Recommendation Neutral
  • P/E Score 1
  • DCF Score 4
  • P/B Score 2
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Upgrade MDT Citigroup Neutral Buy $92 $107 March 4, 2025
Upgrade MDT RBC Capital Mkts Sector Perform Outperform $98 $105 Oct. 10, 2024
Reiterated MDT Oppenheimer -- Perform $92 $94 Aug. 21, 2024

News

Medtronic plc (MDT) Bernstein's 41st Strategic Decisions Conference - (Transcript)
MDT
Published: May 29, 2025 by: Seeking Alpha
Sentiment: Neutral

Medtronic plc (NYSE:MDT ) Bernstein's 41st Strategic Decisions Conference Call May 29, 2025 11:00 AM ET Company Participants Geoff Martha - Chairman and Chief Executive Officer Thierry Pieton - Executive Vice President and Chief Financial Officer Conference Call Participants Lee Hambright - Bernstein Lee Hambright All right. Very good.

Read More
image for news Medtronic plc (MDT) Bernstein's 41st Strategic Decisions Conference - (Transcript)
ISRG vs. MDT: Which Robotic Surgery Stock Is a Smarter Buy Now?
ISRG, MDT
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Neutral

Intuitive Surgical or Medtronic -- who leads the future of robotic surgery? Here's a comparative analysis to help you make a smart choice for 2025.

Read More
image for news ISRG vs. MDT: Which Robotic Surgery Stock Is a Smarter Buy Now?
No Rolex For Me - I'm Buying Dividends That Pay For Life
GD, JNJ, LOW, MCD, MDT, TXN
Published: May 26, 2025 by: Seeking Alpha
Sentiment: Positive

I love luxury watches, but buying more to "earn" access to rarer models made me realize how easy it is to waste capital chasing ego-driven goals. Unlike watches, dividend growth stocks offer reliable long-term returns. A $10K McDonald's investment in 2004 would've yielded over $22K in dividends alone. History shows that strong-yielding dividend stocks, especially those in the second quintile, have consistently outperformed the market with lower risk.

Read More
image for news No Rolex For Me - I'm Buying Dividends That Pay For Life
Medtronic: Diabetes Spin-Off Is Near-Term Catalyst; Rating Upgrade
MDT
Published: May 25, 2025 by: Seeking Alpha
Sentiment: Positive

Upgrading Medtronic to 'Strong Buy' with a $104 fair value, driven by the diabetes business spin-off catalyst. Divesting diabetes enables Medtronic to focus on core cardiac and surgical markets, improving operating margins and capital allocation. Recent results show robust cardiovascular growth and strong shareholder returns, with continued buybacks expected post-spin-off.

Read More
image for news Medtronic: Diabetes Spin-Off Is Near-Term Catalyst; Rating Upgrade
'WIN-WIN': Medtronic CEO explains the reason for diabetes biz spin
MDT
Published: May 22, 2025 by: Fox Business
Sentiment: Positive

Medtronic chairman and CEO Geoff Martha explains why the company is separating the diabetes business on 'The Claman Countdown.' #foxbusiness #usnews #economy #investing #diabetes #health #markets

Read More
image for news 'WIN-WIN': Medtronic CEO explains the reason for diabetes biz spin
Medtronic plc (MDT) Q4 2025 Earnings Call Transcript
MDT
Published: May 21, 2025 by: Seeking Alpha
Sentiment: Neutral

Medtronic plc (NYSE:MDT ) Q4 2025 Earnings Conference Call May 21, 2025 8:00 AM ET Company Participants Ryan Weispfenning - VP and Head of IR Geoff Martha - Chairman and CEO Que Dallara - EVP & President, Diabetes Thierry Pieton - CFO Sean Salmon - EVP and President of Cardiovascular Portfolio Brett Wall - EVP and President of Neuroscience Portfolio Conference Call Participants Travis Steed - Bank of America Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Vijay Kumar - Evercore Joanne Weunsch - Citi Matt Taylor - Jefferies Matt Miksic - Barclays Danielle Antalffy - UBS Shagun Singh …

Read More
image for news Medtronic plc (MDT) Q4 2025 Earnings Call Transcript
Compared to Estimates, Medtronic (MDT) Q4 Earnings: A Look at Key Metrics
MDT
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive

Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Read More
image for news Compared to Estimates, Medtronic (MDT) Q4 Earnings: A Look at Key Metrics
Medtronic to split off its fast-growing diabetes business to unlock its value
MDT
Published: May 21, 2025 by: Market Watch
Sentiment: Positive

The new diabetes company will be predominantly business-to-consumer, while Medtronic's model was more business-to-business.

Read More
image for news Medtronic to split off its fast-growing diabetes business to unlock its value
Medtronic (MDT) Q4 Earnings and Revenues Beat Estimates
MDT
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive

Medtronic (MDT) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.58 per share. This compares to earnings of $1.46 per share a year ago.

Read More
image for news Medtronic (MDT) Q4 Earnings and Revenues Beat Estimates
Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase
MDT
Published: May 21, 2025 by: PRNewsWire
Sentiment: Neutral

Building momentum in key franchises including Pulsed Field Ablation, TAVR, Cardiac Rhythm Management, Diabetes, Spine, and Neuromodulation GALWAY, Ireland , May 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter (Q4) and fiscal year 2025 (FY25), which ended April 25, 2025. Q4 Key Highlights Q4 revenue of $8.9 billion increased 3.9% as reported and 5.4% organic Q4 GAAP diluted EPS of $0.82 increased 67%; non-GAAP diluted EPS of $1.62 increased 11% Q4 operating margin increased 380 basis points; Q4 non-GAAP operating margin increased 90 basis points Q4 …

Read More
image for news Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase
Medtronic announces intent to separate Diabetes business
MDT
Published: May 21, 2025 by: PRNewsWire
Sentiment: Neutral

Enables intense focus on highest margin growth drivers where Medtronic has leading core competencies Leading, scaled, direct-to-consumer Diabetes business poised to become standalone company; only company with a complete ecosystem to address intensive insulin management GALWAY, Ireland , May 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced its intent to separate its Diabetes business into a new standalone company ("New Diabetes Company"). This strategic decision for both Medtronic and New Diabetes Company will create a more focused Medtronic, with a more simplified portfolio in high margin growth markets.

Read More
image for news Medtronic announces intent to separate Diabetes business
Medtronic to separate diabetes business, WSJ reports
MDT
Published: May 21, 2025 by: Reuters
Sentiment: Neutral

Medical device maker Medtronic plans to separate its diabetes business into a stand-alone company, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.

Read More
image for news Medtronic to separate diabetes business, WSJ reports
Medtronic to Separate Diabetes Business
MDT
Published: May 21, 2025 by: WSJ
Sentiment: Neutral

The medical device maker has been working to turn around the division over the last few years.

Read More
image for news Medtronic to Separate Diabetes Business
Will Medtronic's Earnings Move The Stock?
MDT
Published: May 19, 2025 by: Forbes
Sentiment: Neutral

Medtronic (NYSE:MDT) is scheduled to announce its earnings on Wednesday, May 21, 2025. Over the last five years, Medtronic's stock has shown a favorable one-day return following its earnings announcements in 53% of instances.

Read More
image for news Will Medtronic's Earnings Move The Stock?
Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
ABBV, MDT, PFE
Published: May 18, 2025 by: The Motley Fool
Sentiment: Positive

Dividend stocks can be a smart way to generate steady income, especially in uncertain markets. However, not all dividend payers are created equal.

Read More
image for news Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
Trump tariff 'tornado' still hunting markets: Former Medtronic CEO
MDT
Published: May 16, 2025 by: Yahoo Finance
Sentiment: Negative

You can catch Opening Bid on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. There has been one common theme from Corporate America throughout the last two months as the Trump administration's trade war has taken hold: shot-calling CEOs have been frozen in their normally hard-charging tracks.

Read More
image for news Trump tariff 'tornado' still hunting markets: Former Medtronic CEO
What Analyst Projections for Key Metrics Reveal About Medtronic (MDT) Q4 Earnings
MDT
Published: May 16, 2025 by: Zacks Investment Research
Sentiment: Neutral

Get a deeper insight into the potential performance of Medtronic (MDT) for the quarter ended April 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Read More
image for news What Analyst Projections for Key Metrics Reveal About Medtronic (MDT) Q4 Earnings
Should You Continue to Hold Medtronic Stock in Your Portfolio Now?
MDT
Published: May 16, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors stay optimistic about MDT due to its strength in the Cardiovascular portfolio.

Read More
image for news Should You Continue to Hold Medtronic Stock in Your Portfolio Now?
Medtronic: Quite A Few Supportive Sub-Plots Ahead Of The Q4-25 Earnings
MDT
Published: May 14, 2025 by: Seeking Alpha
Sentiment: Positive

Medtronic has outperformed the S&P500 and other healthcare stocks from the S&P500 this year, but now faces a pivotal earnings event on the 21st of May. Cardiovascular portfolio strength, especially from Pulse Field Ablation products, and a convalescing medical surgical outlook, underpin our optimism, while gross margin and SG&A progress is likely to be seen. While the expected dividend hike may not be meaningful (potentially at less than 2%), that's not because MDT doesn't have the capabilities to be more generous with strong FCF coverage.

Read More
image for news Medtronic: Quite A Few Supportive Sub-Plots Ahead Of The Q4-25 Earnings
Medtronic to announce financial results for its fourth quarter and full fiscal year 2025
MDT
Published: May 07, 2025 by: PRNewsWire
Sentiment: Neutral

GALWAY, Ireland , May 7, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2025 on Wednesday, May 21, 2025. A news release will be issued at approximately 5:45 a.m.

Read More
image for news Medtronic to announce financial results for its fourth quarter and full fiscal year 2025
New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women
MDT
Published: May 07, 2025 by: PRNewsWire
Sentiment: Neutral

Star Jones, award winning television personality & women's heart health advocate, helps kick off heart health conversations this Mother's Day with the Medtronic 'Letter to My Mother' campaign GALWAY, Ireland , May 7, 2025 /PRNewswire/ -- A new Medtronic-sponsored survey of women ages 30-50 reveals a significant gap in awareness and discussion around heart health among women and their mother-figures. Despite cardiovascular disease being the #1 killer of women in the U.S., many women are still unaware of the risk and the importance of heart health.

Read More
image for news New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women
Smart Pills Market Industry Trend Analysis, and Forecast 2025-2034, with Profiles of ANX Robotica, Bodycap, CapsoVision, Check-Cap, etectRx, Intromedic, Medtronic, Otsuka, Olympus and RF
MDT
Published: April 30, 2025 by: GlobeNewsWire
Sentiment: Neutral

Key growth drivers include the rise of gastrointestinal disorders and demand for non-invasive diagnostics. Smart pills, equipped with sensors and AI, facilitate real-time monitoring and personalized medicine. North America leads with USD 455.5 million in 2024. The market benefits from tech advancements, an aging population, and robust healthcare infrastructure, paving the way for continuous growth. Key growth drivers include the rise of gastrointestinal disorders and demand for non-invasive diagnostics. Smart pills, equipped with sensors and AI, facilitate real-time monitoring and personalized medicine. North America leads with USD 455.5 million in 2024. The market benefits from tech advancements, an aging population, …

Read More
image for news Smart Pills Market Industry Trend Analysis, and Forecast 2025-2034, with Profiles of ANX Robotica, Bodycap, CapsoVision, Check-Cap, etectRx, Intromedic, Medtronic, Otsuka, Olympus and RF
2 Outstanding Dividend Stocks to Buy and Hold For 20 Years
MDT, MRK
Published: April 26, 2025 by: The Motley Fool
Sentiment: Positive

Many investors are withdrawing their money from the stock market right now, but those focused on the long term know to hold on through market volatility. In fact, it's still a great time to invest in companies that have excellent underlying businesses and attractive long-term prospects.

Read More
image for news 2 Outstanding Dividend Stocks to Buy and Hold For 20 Years
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
MDT
Published: April 26, 2025 by: PRNewsWire
Sentiment: Neutral

Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted urologic surgery in the U.S. presented as a late-breaker at the American Urologic Association annual meeting Company confirms Hugo RAS system submission to the U.S. Food and Drug Administration GALWAY, Ireland and LAS VEGAS , April 26, 2025 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced that the Expand URO Investigational Device Exemption (IDE) clinical study, the largest such study for robotic-assisted urologic surgery ever conducted, met both primary safety and effectiveness endpoints. The prospective, multi-center, single-arm IDE study included 137 patients who underwent …

Read More
image for news Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
Prediction: Buying Medtronic Today Will Set You Up for Life
MDT
Published: March 28, 2025 by: The Motley Fool
Sentiment: Positive

Healthcare can be a complex sector, and it is one that I long ago decided to outsource to the industry professionals who run closed-end fund Blackrock Health Sciences Trust. But I couldn't resist dipping my toe into the sector when I saw the historically high yield on offer from Medtronic (MDT 0.88%), one of the largest and most diversified medical device makers.

Read More
image for news Prediction: Buying Medtronic Today Will Set You Up for Life
2 Recession-Proof Dividend Stocks to Buy and Hold
JNJ, MDT
Published: March 27, 2025 by: The Motley Fool
Sentiment: Neutral

Fears of a looming recession seem to be rising, partly fueled by President Donald Trump's macroeconomic policies. While it's impossible to predict whether an economic downturn is indeed coming, it's not a bad idea for investors to purchase shares of companies that are likely to perform relatively well in case it does happen.

Read More
image for news 2 Recession-Proof Dividend Stocks to Buy and Hold
Does the S&P 500 Rally Make MDT Stock a Buy Amid Easing Trade Tension?
MDT
Published: March 25, 2025 by: Zacks Investment Research
Sentiment: Neutral

Medtronic's Hypertension business is on the brink of a major expansion, driven by its Simplicity blood pressure procedure.

Read More
image for news Does the S&P 500 Rally Make MDT Stock a Buy Amid Easing Trade Tension?
Watch These 5 AI-Powered Healthcare Bigwigs for Portfolio Gains
ABT, BSX, LLY, MDT, NVS
Published: March 24, 2025 by: Zacks Investment Research
Sentiment: Positive

Five AI-powered stocks have strong revenues and earnings growth potentials for 2025. These are: MDT, LLY, BSX, NVS, ABT.

Read More
image for news Watch These 5 AI-Powered Healthcare Bigwigs for Portfolio Gains
Medtronic: Strength In Cardiac Ablation Solutions, Upgrade To Buy
MDT
Published: March 19, 2025 by: Seeking Alpha
Sentiment: Positive

Upgraded Medtronic to a ‘Buy' rating with a fair value of $105 per share, driven by strong growth in Cardiac Ablation Solutions and TAVR markets. Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth, highlighting significant momentum in its Cardiac Ablation Solutions business. The company's structural heart business, especially the Evolut FX+ TAVR system, is showing strong adoption and competitive advantages over Edwards Lifesciences's SAPIEN TAVR product.

Read More
image for news Medtronic: Strength In Cardiac Ablation Solutions, Upgrade To Buy
FDA classifies recall of Medtronic embolization devices as 'most serious'
MDT
Published: March 18, 2025 by: Reuters
Sentiment: Negative

The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", following reports of the deaths of four patients.

Read More
image for news FDA classifies recall of Medtronic embolization devices as 'most serious'

About Medtronic plc (MDT)

  • IPO Date 1973-05-02
  • Website https://www.medtronic.com
  • Industry Medical - Devices
  • CEO Mr. Geoffrey Straub Martha
  • Employees 95000

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.